Yuvaraj Jeremy, Cameron William, Andrews Jordan, Lin Andrew, Nerlekar Nitesh, Nicholls Stephen J, Hamilton Garun S, Wong Dennis T L
Monash Cardiovascular Research Centre, Victorian Heart Institute, Monash University and MonashHeart, Monash Health, Clayton, Melbourne, VIC, Australia.
School of Clinical Sciences, Monash University, Clayton, Melbourne, VIC, Australia.
Cardiovasc Diagn Ther. 2022 Feb;12(1):123-134. doi: 10.21037/cdt-21-338.
Obstructive sleep apnoea (OSA) is associated with increased coronary artery disease (CAD) plaque burden, but the role of vascular inflammation in this relationship is unclear. Coronary computed tomography angiography (CTA) enables surrogate assessment of systemic inflammation via subcutaneous adipose tissue attenuation (SCAT-a), and of coronary inflammation via epicardial adipose tissue volume and attenuation (EAT-v and EAT-a) and pericoronary adipose tissue attenuation (PCAT-a). We investigated whether patients with severe OSA and high plaque burden have increased vascular inflammation.
Patients with overnight polysomnography within ≤12 months of coronary CTA were included. Severe OSA was classified as apnoea/hypopnoea index (AHI) >30. High plaque burden was defined as a CT-adapted Leaman score (CT-LeSc) ≥8.3. Patients with both severe OSA and high plaque burden were defined as 'Group 1', all other patients were classified as 'Group 2'. ScAT, PCAT and EAT attenuation and volume were assessed on semi-automated software.
A total of 91 patients were studied (59.3±11.1 years). Severe OSA was associated with high plaque burden (P=0.02). AHI correlated with CT-LeSc (r=0.24, P=0.023). Group 1 had lower EAT-a and PCAT-a compared to Group 2 (EAT-a: -87.6 -84.0 HU, P=0.011; PCAT-a: -90.4 -83.4 HU, P<0.01). However, among patients with low plaque burden, EAT-a was higher in the presence of severe OSA versus mild-moderate OSA (-80.3 -84.0 HU, P=0.020). On multivariable analysis, severe OSA and high plaque burden associated with EAT-a (P<0.02), and severe OSA and high plaque burden (P<0.01) and hypertension (P<0.01) associated with PCAT-a.
EAT and PCAT attenuation are decreased in patients with severe OSA and high plaque burden, but EAT attenuation was increased in patients with severe OSA and low plaque burden. These divergent results suggest vascular inflammation may be increased in OSA independent of CAD, but larger studies are required to validate these findings.
阻塞性睡眠呼吸暂停(OSA)与冠状动脉疾病(CAD)斑块负荷增加有关,但血管炎症在这种关系中的作用尚不清楚。冠状动脉计算机断层扫描血管造影(CTA)能够通过皮下脂肪组织衰减(SCAT-a)替代评估全身炎症,通过心外膜脂肪组织体积和衰减(EAT-v和EAT-a)以及冠状动脉周围脂肪组织衰减(PCAT-a)评估冠状动脉炎症。我们研究了重度OSA和高斑块负荷患者的血管炎症是否增加。
纳入在冠状动脉CTA检查后≤12个月内进行过夜多导睡眠监测的患者。重度OSA定义为呼吸暂停/低通气指数(AHI)>30。高斑块负荷定义为CT适应性Leaman评分(CT-LeSc)≥8.3。同时患有重度OSA和高斑块负荷的患者定义为“第1组”,所有其他患者分类为“第2组”。在半自动软件上评估SCAT、PCAT以及EAT的衰减和体积。
共研究了91例患者(年龄59.3±11.1岁)。重度OSA与高斑块负荷相关(P = 0.02)。AHI与CT-LeSc相关(r = 0.24,P = 0.023)。与第2组相比,第1组的EAT-a和PCAT-a较低(EAT-a:-87.6 -84.0 HU,P = 0.011;PCAT-a:-90.4 -83.4 HU,P<0.01)。然而,在低斑块负荷患者中,重度OSA患者的EAT-a高于轻度至中度OSA患者(-80.3 -84.0 HU,P = 0.020)。多变量分析显示,重度OSA和高斑块负荷与EAT-a相关(P<0.02),重度OSA和高斑块负荷(P<0.01)以及高血压(P<0.01)与PCAT-a相关。
重度OSA和高斑块负荷患者的EAT和PCAT衰减降低,但重度OSA和低斑块负荷患者的EAT衰减增加。这些不同的结果表明,OSA患者的血管炎症可能在独立于CAD的情况下增加,但需要更大规模的研究来验证这些发现。